Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 986, pseudogene (RNU6-986P) is a human pseudogene derived from the U6 small nuclear RNA (snRNA) gene family[2][8]. The U6 snRNA is an essential, highly conserved component of the spliceosome—an RNA-protein complex crucial for pre-mRNA splicing in eukaryotes[3][1]. However, RNU6-986P itself is a non-functional copy (pseudogene) of the U6 snRNA gene, containing sequence homology to the functional U6 gene but generally not producing a functional RNA or protein product[2][5][8]. Pseudogenes like RNU6-986P may sometimes be transcribed, and in some cases, pseudogene transcripts can regulate gene expression by acting as antisense RNAs, small interfering RNAs (siRNAs), or competitive endogenous RNAs (ceRNAs)[4]; there is no direct evidence that RNU6-986P has such regulatory activities. It is not considered a therapeutic target, receptor, enzyme, transporter, or regulator, and has no known associated drugs, biomarker utility, or safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 986, pseudogene (RNU6-986P).